E-LIB Suche - Ergebnisse für: Dezentjé, V.

1

Influence of HER2 expression on prognosis in metastatic tri..:

Gampenrieder, S.P. ; Dezentjé, V. ; Lambertini, M....
ESMO Open. 8 (2023) 1 - p. 100747 , 2023

2

Toward omitting sentinel lymph node biopsy after neoadjuvan..:

van der Noordaa, M E M ; van Duijnhoven, F H ; Cuijpers, F N E...
British Journal of Surgery. 108 (2020) 6 - p. 667-674 , 2020

Link: https://doi.org/10.1002/..

3

Omitting sentinel lymph node biopsy after neoadjuvant syste..:

Van der Noordaa, M. ; Van Duijnhoven, F. ; Cuijpers, V....
European Journal of Cancer. 92 (2018) - p. S14 , 2018

Link: https://doi.org/10.1016/..

4

Breast conserving therapy after neoadjuvant systemic therap..:

Van der Noordaa, M. ; Vrancken Peeters, M.J. ; Ioan, I....
European Journal of Cancer. 92 (2018) - p. S82-S83 , 2018

Link: https://doi.org/10.1016/..

5

Combined Cabazitaxel and Carboplatin Treatment of Metastati..:

van der Zande, K. ; Tutuhatunewa-Louhanepessy, R.D. ; Hamberg, P....
Clinical Genitourinary Cancer. 22 (2024) 2 - p. 445-453.e1 , 2024

Link: https://doi.org/10.1016/..

6

Intra-Arterial Therapies for Liver Metastatic Breast Cancer..:

Aarts, B. M. ; Muñoz, F. M. Gómez ; Wildiers, H....
CardioVascular and Interventional Radiology. 44 (2021) 12 - p. 1868-1882 , 2021

Link: https://doi.org/10.1007/..

7

Effect of CYP2C19 genotypes on tamoxifen metabolism and ear..:

Sanchez-Spitman, A. B. ; Swen, J. J. ; Dezentjé, V. O....
Scientific Reports. 11 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

8

Clinical pharmacokinetics and pharmacogenetics of tamoxifen..:

Sanchez-Spitman, A.B. ; Swen, J.J. ; Dezentje, V.O....
Expert Review of Clinical Pharmacology. 12 (2019) 6 - p. 523-536 , 2019

Link: https://doi.org/10.1080/..

9

Genetic polymorphisms of 3′-untranslated region of SULT1A1 ..:

Sanchez-Spitman, A. B. ; Dezentjé, V. O. ; Swen, J. J....
Breast Cancer Research and Treatment. 172 (2018) 2 - p. 401-411 , 2018

Link: https://doi.org/10.1007/..

10

Effect of CYP3A422, CYP3A53, and CYP3A combined genotypes..:

Sanchez Spitman, A. B. ; Moes, D. J. A. R. ; Gelderblom, H....
European Journal of Clinical Pharmacology. 73 (2017) 12 - p. 1589-1598 , 2017

Link: https://doi.org/10.1007/..

11

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escala..:

Dezentjé, V. O. ; Opdam, F. L. ; Gelderblom, H....
Breast Cancer Research and Treatment. 153 (2015) 3 - p. 583-590 , 2015

Link: https://doi.org/10.1007/..

12

CYP2D6 genotype in relation to tamoxifen efficacy in a Dutc..:

Dezentjé, V. O. ; van Schaik, R. H. N. ; Vletter-Bogaartz, J. M....
Breast Cancer Research and Treatment. 140 (2013) 2 - p. 363-373 , 2013

Link: https://doi.org/10.1007/..

13

Erratum to: The use of the 13C-dextromethorphan breath test..:

Opdam, F. L. ; Dezentje, V. O. ; den Hartigh, J....
Cancer Chemotherapy and Pharmacology. 71 (2013) 3 - p. 603-603 , 2013

Link: https://doi.org/10.1007/..

14

The use of the 13C-dextromethorphan breath test for phenoty..:

Opdam, F. L. ; Dezentje, V. O. ; den Hartigh, J....
Cancer Chemotherapy and Pharmacology. 71 (2012) 3 - p. 593-601 , 2012

Link: https://doi.org/10.1007/..

15

Clinical implications of CYP2D6 genotyping on tamoxifen tre..:

Dezentje, V.O. ; Nortier, J.W.R. ; Guchelaar, H.J...
European Journal of Cancer Supplements. 6 (2008) 7 - p. 56 , 2008

Link: https://doi.org/10.1016/..